tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Verrica Pharmaceuticals reports Q3 adjusted EPS 13c, consensus (84c)
PremiumThe FlyVerrica Pharmaceuticals reports Q3 adjusted EPS 13c, consensus (84c)
29d ago
Verrica Pharmaceuticals presents new data on VP-315 from Phase 2 trial
Premium
The Fly
Verrica Pharmaceuticals presents new data on VP-315 from Phase 2 trial
1M ago
VRCA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VRCA Earnings this Week: How Will it Perform?
1M ago
Verrica Pharmaceuticals: Promising Sales Growth Amid Financial Stability Concerns
PremiumRatingsVerrica Pharmaceuticals: Promising Sales Growth Amid Financial Stability Concerns
4M ago
Verrica Pharmaceuticals Sees Revenue Surge in Q2 2025
Premium
Company Announcements
Verrica Pharmaceuticals Sees Revenue Surge in Q2 2025
4M ago
Promising Sales Growth and Strategic Initiatives Drive Buy Rating for Verrica Pharmaceuticals
Premium
Ratings
Promising Sales Growth and Strategic Initiatives Drive Buy Rating for Verrica Pharmaceuticals
4M ago
Verrica Pharmaceuticals Announces Reverse Stock Split
PremiumCompany AnnouncementsVerrica Pharmaceuticals Announces Reverse Stock Split
5M ago
Verrica reports 13,434 YCANTH dispensed applicator units in Q2
Premium
The Fly
Verrica reports 13,434 YCANTH dispensed applicator units in Q2
5M ago
Verrica Pharmaceuticals Amends Collaboration for YCANTH Trial
Premium
Company Announcements
Verrica Pharmaceuticals Amends Collaboration for YCANTH Trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100